Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar-Apr;73(2):242-243.
doi: 10.1016/j.ihj.2021.01.019. Epub 2021 Jan 29.

'Digoxin conundrum - Time for validation?'

O P Yadava  1
Affiliations

'Digoxin conundrum - Time for validation?'

O P Yadava. Indian Heart J. 2021 Mar-Apr.

Abstract

Despite no incontrovertible data, Digoxin use has been demonised. As a consequence, a lot of patients, stable on Digoxin, have been taken off it and offered alternative drugs. However, there is some light at the end of the tunnel for Digoxin, with the reporting of RATE-AF Trial at the recent European Society of Cardiology Congress. Compared to Bisoprolol, Digoxin use was associated with statistically significantly greater improvements in symptomatology and NT ProBNP levels making Digoxin a first line drug for rate control in permanent AF.

Keywords: Atrial fibrillation; Digoxin; Heart failure.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Turakhia M.P. Digoxin in atrial fibrillation? Leave it out of the medicine cabinet. J Am Coll Cardiol. 2018;71(10):1075–1077. - PubMed
    1. Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336(8):525–533. - PubMed
    1. Ziff O.J., Lane D.A., Samra M. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. BMJ. 2015;351:h4451. - PMC - PubMed
    1. John M. vol. 30. 2020. (Mandrola. Digoxin Stuns in RATE-AF Trial - Medscape - Aug).
    1. Kotecha D., Calvert M., Deeks J.J. A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial. ESC Virtual Congress. 2020 - PMC - PubMed